Par Drugs and Chemicals Limited — Board Meeting, 08-08-2026: Outcome of Board Meeting
08-08-2026 | 05:23 pm
08-08-2026 | 05:23 pm
Par Drugs and Chemicals' Board approved the financial results for the quarter, reporting revenue of ₹32.22 Cr and profit of ₹4.71 Cr. The board also greenlit new banking facilities, appointed NEO Alternative Asset Managers as Portfolio Manager, and approved vehicle asset updates including new purchases.
No comments yet. Be the first to comment!
